The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Improved transfusion independence rates for momelotinib versus ruxolitinib in anemic JAKi naïve myelofibrosis patients independent of baseline platelet or transfusion status.
 
Jean-Jacques Kiladjian
No Relationships to Disclose
 
Uwe Platzbecker
Honoraria - Celgene/Jazz
Consulting or Advisory Role - Celgene/Jazz
Research Funding - Amgen (Inst); BerGenBio (Inst); Celgene (Inst); Janssen (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - part of a patent for a TFR-2 antibody (Rauner et al. Nature Metabolics 2019)
Travel, Accommodations, Expenses - Celgene
 
Jiří Mayer
Research Funding - Abbvie; Principa Biopharma
 
Árpád Illés
Consulting or Advisory Role - Celgene; Janssen; Novartis; Pfizer; Roche; Takeda
Research Funding - Seagen; Takeda
Travel, Accommodations, Expenses - Janssen; Novartis; Pfizer; Roche
 
Witold Prejzner
No Relationships to Disclose
 
Tomasz Woźny
No Relationships to Disclose
 
Nikolay Tzvetkov
No Relationships to Disclose
 
Alessandro M. Vannucchi
Consulting or Advisory Role - Abbvie; Blueprint Medicines; Celgene/Bristol-Myers Squibb; Incyte; Novartis
 
Ilya Kirgner
No Relationships to Disclose
 
Zsolt Nagy
No Relationships to Disclose
 
Sebastian Grosicki
No Relationships to Disclose
 
Åsa Derolf
No Relationships to Disclose
 
Mihaela Cornelia Lazaroiu
No Relationships to Disclose
 
Sung-Soo Yoon
Honoraria - Novartis
Consulting or Advisory Role - Amgen; Celgene/Jazz; Janssen; Takeda
Research Funding - Kyowa Kirin; Roche/Genentech; Yuhan
 
Yeow Tee Goh
Research Funding - Pfizer
 
Nikolas von Bubnoff
Honoraria - Amgen; AstraZeneca; BMS; Novartis; Novartis; Takeda
Consulting or Advisory Role - Novartis (Inst)
Research Funding - Novartis (Inst)
 
Srdan Verstovsek
Consulting or Advisory Role - Celgene; Constellation Pharmaceuticals; Incyte; Novartis; Sierra Oncology
Research Funding - Blueprint Medicines; Celgene; CTI BioPharma Corp; Genentech; Gilead Sciences; Incyte; Novartis; NS Pharma; Promedior; Roche
 
Barbara J. Klencke
Employment - Sierra Oncology
Stock and Other Ownership Interests - Sierra Oncology
 
Rafe Donahue
Employment - Sierra Oncology
Stock and Other Ownership Interests - Sierra Oncology
 
Ruben A. Mesa
Honoraria - Abbvie; AOP Orphan Pharmaceuticals; BMS; Geron; Novartis; shire; Sierra Oncology
Consulting or Advisory Role - Baxalta; Galena Biopharma; Incyte; Novartis
Research Funding - Abbvie (Inst); Celgene (Inst); CTI (Inst); Genentech (Inst); Gilead Sciences (Inst); Imago Pharma (Inst); Incyte (Inst); NS Pharma (Inst); Pfizer (Inst); Pharmaessentia (Inst); Promedior (Inst)
Travel, Accommodations, Expenses - AOP Orphan Pharmaceuticals; Incyte; Novartis; Pharmaessentia